# Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma

> **NCT04178616** · NA · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 59 (actual)

## Conditions studied

- Olfactory Disorders
- Scleroderma

## Interventions

- **DIAGNOSTIC_TEST:** olfactory testing with specific odorants (localisation and identification)

## Key facts

- **NCT ID:** NCT04178616
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-31
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Following the COVID-related health crisis, nasofibroscopic sampling could no longer be carried out
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04178616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04178616, "Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04178616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*